U.S. Markets close in 1 hr 34 mins

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
20.71-1.32 (-5.97%)
As of 2:25PM EDT. Market open.
People also watch
TGTXPTLAFOLDSGYPOCUL
  • B
    Brian
    Brian
    I am shocked that the stock has dropped so much with only 3 million shares dilution. We be the rev estimates by quite a lot and now have a lot of cash on hand. Also positive news with the drugs. Amazes me we drop so much.
  • J
    J
    J
    Drifting half a dollar lower for no reason makes me sick
  • B
    Brendan Mc
    Brendan Mc
    Relax 😎
  • b
    ben
    ben
    Below PPS Cantor paid for the secondary.
  • J
    J
    J
    Hopefully a good start to the week
  • M
    Moses
    Moses
    This is what happens when you give the shorts free money like Dr D did last week. Doesn't seem like a big deal until later.
  • b
    ben
    ben
    UP 100% YTD, secondary buyers are down $2. a share should turn around soon.
  • J
    Joe
    Joe
    Price will be up and down before FDA approves. Just fasten the belts!
  • J
    John
    John
    MU and OMER being F with today. Some crooks want in real bad
  • J
    Joe
    Joe
    @the self proclaimed Guru....I told you we would see $21 before we see $25 again. I guess you are buying more.
  • b
    ben
    ben
    Good week for Omeros as they secured anywhere from $63-71 million. Now let's get the Protocols set with the FDA and commence P3 , the lawsuits behind us and anything else that might be perceived as negative.
  • b
    brian
    brian
    GreatDayMoron - Did you Delete that you added 10,000 shares at $22.50 last week?
    Imagehaidaspicciare
  • b
    ben
    ben
    Until we get real news PPS will drift, probably lower.
  • G
    GreatDayStockGuruInCA
    GreatDayStockGuruInCA
    Secondary Offering ought to have closed Friday...
  • M
    Matthew
    Matthew
    I'm a bit new to this, but this company is incredibly leveraged and a long way to go to make a profit. Their released med only impacts like 7,500 people. Why is this company so appealing? I haven't had a chance to dig into their other potential drugs too much yet.
  • J
    J
    J

    https://seekingalpha.com/article/4100680-balanced-take-omeros

    A Balanced Take On Omeros
    OMER markets Omidria which brings in revenues, but not enough to fund operations yet. The current valuation suggests the market expects big things for the compa
    seekingalpha.com
  • b
    ben
    ben
    Not much support Cantor.
  • s
    siserv2001
    siserv2001
    My options expired and I made a very nice return! Now hope they make an EU partnership announcement soon and then a CE mark would be icing on the cake! Lots of studys and just waiting on results!
  • J
    Joe
    Joe
    I bought 2000 shares in the dip. Great buy opportunity!
  • d
    david
    david
    I remember when the price was $7 , so $22 not to hard to swallow. I still like Webs call at $75!